http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111978360-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-04 |
| filingDate | 2020-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-111978360-B |
| titleOfInvention | Ulva B3S type sulfated oligosaccharide compound and its preparation method and application |
| abstract | The invention relates to an Ulva B 3S type sulfated oligosaccharide compound, which is formed by linking L-iduronic acid and L-rhamnose 3 sulfate through α-1,4 glycosidic bonds. The oligosaccharide compound is synthesized Methods Stereospecific construction of α-1,4 glycosidic bonds between L-iduronic acid building blocks and L-rhamnose building blocks based on gold-catalyzed glycosidation of glycosyl alkynoid ester donors . The present invention also relates to the immune enhancement function evaluation of the oligosaccharide compound based on Raw264.7 cells. |
| priorityDate | 2020-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 101.